FDA Inspection 1181230 — LifeShare Blood Center

LifeShare Blood Center — FEI 2377718

The FDA completed an inspection of LifeShare Blood Center on September 14, 2022 in Alexandria, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Alexandria, LA (United States)